Featured

Ireland continues to rank among the bottom of Western European countries when it comes to availability of newly licensed cancer treatments, according to a new report by data analysts IQVIA for EFPIA, the European pharmaceutical body.

Today, (Wednesday 26th February) the Irish Pharmaceutical Healthcare Association (IPHA) publishes a position paper on the 2025 Programme for Government Commitments which makes the case for Faster and Fairer Access to Medicines.

Central to IPHA’s General Election manifesto is an ask for the next Government to commit to a continuous and faster flow of new life-enhancing medicines, and vaccines, for patients in Ireland. The manifesto outlines innovative proposals on how this can be achieved.